EXTON, Pa.- Fibrocell Science, Inc. (OTCBB:FCSC.OB) a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that David Pernock, the Company’s Chairman and CEO, will be presenting at the Rodman & Renshaw 13th Annual Healthcare Conference to be held on September 11-13, 2011 at The Waldorf Astoria Hotel in New York.

Fibrocell’s presentation is scheduled for Tuesday, September 13, at 10:25 a.m. Eastern Time.

The presentation will be webcast live, and a replay will be available on the Investors section of the Company’s website at fibrocellscience.com

About Fibrocell Science, Inc.

Fibrocell Science, Inc. (OTCBB:FCSC.OB) is a biotechnology company focused on the development of regenerative cell therapy for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well as its innovative cellular processing technology and manufacturing excellence. For additional information, please visit fibrocellscience.com.

CONTACTS:

Media
Marina Maher Communications
Jessica Morrison
(212) 485-6806
jmorrison@mahercomm.com

Investors
ICR, LLC
Sherry Bertner
Managing Director
(646) 277-1247
sherry.bertner@icrinc.com